Academy of Translational Medicine Director, Dr. Poul Sorensen, is visiting Technical University Munich to learn how this top German university does its translational research
Dr. Poul Sorensen, Professor of Pathology and Laboratory Medicine and Director of the Academy of Translational Medicine (ATM) at UBC, is taking a short 4-month sabbatical at Technical University Munich (TUM) in the Southern German city to gain insights into how the German system supports translational medical research.
UBC team discovers ‘silver bullet’ to keep medical devices free of bacteria
The silver-based coating could be applied to many different medical products.
ATM’s Entrepreneurship Micro-Course Series Receives SIF Funding
The ATM is excited to announce that its proposal, Mini entrepreneurship-portfolio to kickstart a translational medicine education platform, has been awarded $100,562 by UBC Faculty of Medicine’s Strategic Investment Fund (SIF).
A GRAND PLAN TO RID THE WORLD OF CANCER, DIABETES, ALZHEIMER’S, AND MORE
A recent Pathways Magazine issue featured UBC's translational medicine achievements and initiatives.
ATM Visiting Professorship Program – Inaugural Award
We are very excited to welcome Dr. Stefan Burdach as the inaugural Academy of Translational Medicine (ATM) Visiting Professor to the University of British Columbia.
Harnessing the regulatory process to fuel bio-innovation, improve health
B.C. is home to a booming biomedical sector that is turning scientific discoveries into life-saving treatments and preventions.
The Academy of Translational Medicine in Pathology Newsletter
BC has a distinct opportunity to lead this global transformation and shape a more healthy, sustainable, and innovative future for British Columbia.
Dean Regier appointed Chair for the new Regulatory Advisory Council at Academy of Translational Medicine
He will provide leadership to establish the Regulatory Advisory Council and the Academy of Translational Medicine as leaders in regulatory affairs in Canada.
Halting COVID-19 in its tracks
UBC researchers are investigating a novel aerosol treatment to stop the virus from replicating.